Novo Nordisk Presents New Data on Wegovy, Women’s Obesity
Novo Nordisk will bring 52 abstracts to the European Congress on Obesity (ECO) in Istanbul, May 12–15, spotlighting its...
No videos found.
Study Reveals Under-recognised Genetic Driver for Adult FSGS
Purespring Therapeutics has published a population modeling study in Kidney International Reports indicating that pathogenic NPHS2 variants are a...
Plus Therapeutics Secures Blue Shield Coverage for CNSide Assay
CNSide Diagnostics, a subsidiary of Plus Therapeutics, secured payer coverage from Blue Shield of California for its CNSide Cerebrospinal...
Organogenesis Delivers Complete Renu® Biologics Application
Organogenesis has completed a rolling Biologics License Application to the FDA for Renu, a cryopreserved amniotic suspension allograft for...
Mesoblast Hits Recruitment Target for Chronic Back Pain Trial
Mesoblast has completed enrollment in its pivotal Phase 3 trial of rexlemestrocel-L for chronic low back pain due to...
Coultreon’s $125M Bet Proves the Real Alpha in Biotech Is Knowing Which Shipwrecks Are Worth Salvaging
Coultreon Biopharma raised $125M Series A for rescued Galapagos oncology assets — and the investor syndicate tells you exactly...
Novartis Q1 Growth Surges; 2026 Forecast Reaffirmed
Novartis opened 2026 with a mixed first quarter: net sales declined 5% at constant currency and core operating income...
Siren Biotech Publishes Foundational AAV Immuno-Gene Data
Siren Biotechnology has published its first peer-reviewed data in Molecular Therapy Oncology on a universal AAV immuno-gene therapy platform...
Exparel Data: Breakthrough in Lowering Opioid Use & Costs
Pacira BioSciences reported new real-world evidence showing its long-acting local anesthetic, EXPAREL (bupivacaine liposome injectable suspension), was associated with...
Arcutis Submits Zoryve sNDA to FDA for Infants, Babies
Arcutis has filed a supplemental NDA with the FDA to extend ZORYVE (roflumilast) cream 0.05% to infants aged 3...